Summarized: California's Latest, Proposed, Research Spending Priorities for $3.9 Billion in Stem Cell/Gene Therapies
Here is how the California Institute for Regenerative Medicine (CIRM) summarized its new priorities for its priority review committees as of Sept. 10, 2024.
The version below was prepared by CIRM prior to a vote by the committees Sept. 13 to send the plan to the full CIRM board on Sept. 26. The proposal may be modified prior to final approval by the board or by the board during the Sept. 26 meeting.
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.